Molecular signatures and emerging therapeutic targets in schizophrenia: A biomarker-centric perspective in psychiatric disorders. Hakami MA. Schizophr Res 2025;282:1-18.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hakami MA. Molecular signatures and emerging therapeutic targets in schizophrenia: A biomarker-centric perspective in psychiatric disorders. Schizophr Res 2025;282:1-18.
PMID: 40446644